Stocks and Investing Stocks and Investing
Thu, July 27, 2023

Jonathan Yong Reiterated (AMED) at Hold and Held Target at $101 on, Jul 27th, 2023


Published on 2024-10-28 05:10:47 - WOPRAI, Jonathan Yong
  Print publication without navigation


Jonathan Yong of Credit Suisse, Reiterated "Amedisys, Inc." (AMED) at Hold and Held Target at $101 on, Jul 27th, 2023.

Jonathan has made no other calls on AMED in the last 4 months.



There are 7 other peers that have a rating on AMED. Out of the 7 peers that are also analyzing AMED, all agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $101 on, Thursday, July 6th, 2023
  • Bill Sutherland of "Benchmark" Downgraded from Strong Buy to Hold on, Wednesday, June 28th, 2023
  • David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $101 on, Tuesday, June 27th, 2023
  • Sarah James of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $100 on, Tuesday, June 6th, 2023
  • Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
  • Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023
Contributing Sources